Aspen Aerogels (ASPN) – Research Analysts’ Recent Ratings Changes

Several analysts have recently updated their ratings and price targets for Aspen Aerogels (NYSE: ASPN):

• 11/13/2024 – Aspen Aerogels was upgraded by analysts at StockNews.com to a “sell” rating.
• 11/12/2024 – Aspen Aerogels had its price target lowered by analysts at Barclays PLC from $27.00 to $25.00. They now have an “overweight” rating on the stock.
• 11/8/2024 – Aspen Aerogels had its price target lowered by analysts at Roth Mkm from $36.00 to $31.00. They now have a “buy” rating on the stock.
• 10/31/2024 – Aspen Aerogels was upgraded by analysts at StockNews.com to a “sell” rating.
• 10/22/2024 – Aspen Aerogels had its price target lowered by analysts at Piper Sandler from $36.00 to $33.00. They now have an “overweight” rating on the stock.
• 10/16/2024 – Aspen Aerogels had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.

Aspen Aerogels Stock Up 0.5 %

ASPN stock traded up $0.07 during trading on Thursday, reaching $14.05. The stock had a trading volume of 1,567,321 shares, compared to its average volume of 1,624,822. Aspen Aerogels, Inc. has a one year low of $10.31 and a one year high of $33.15. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The company’s 50 day moving average is $21.48 and its two-hundred day moving average is $24.50. The company has a market capitalization of $1.15 billion, a price-to-earnings ratio of 1,406.74 and a beta of 2.21.

Insiders Place Their Bets

In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the transaction, the chief financial officer now directly owns 20,790 shares of the company’s stock, valued at $626,610.60. This represents a 60.96 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Donald R. Young sold 63,355 shares of the stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the transaction, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at $14,523,709.20. This represents a 11.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Aspen Aerogels

Institutional investors and hedge funds have recently made changes to their positions in the business. Driehaus Capital Management LLC grew its holdings in Aspen Aerogels by 130.4% in the 2nd quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock worth $51,439,000 after acquiring an additional 1,220,724 shares during the last quarter. FMR LLC lifted its position in Aspen Aerogels by 23.6% during the 3rd quarter. FMR LLC now owns 4,050,896 shares of the construction company’s stock valued at $112,169,000 after acquiring an additional 773,647 shares during the period. American Century Companies Inc. lifted its position in Aspen Aerogels by 562.3% during the 2nd quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock valued at $18,382,000 after acquiring an additional 654,350 shares during the period. Millennium Management LLC purchased a new position in Aspen Aerogels in the second quarter worth about $9,339,000. Finally, Hood River Capital Management LLC raised its holdings in Aspen Aerogels by 12.2% in the first quarter. Hood River Capital Management LLC now owns 3,300,443 shares of the construction company’s stock worth $58,088,000 after buying an additional 357,895 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.